Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-FR Version v5-FR
Language French French
Date Updated 2022-09-26 2022-06-01
Drug Identification Number 02240351 02240351
Brand name INTEGRILIN INTEGRILIN
Common or Proper name eptifibatide injection eptifibatide injection
Company Name MERCK CANADA INC MERCK CANADA INC
Ingredients EPTIFIBATIDE EPTIFIBATIDE
Strength(s) 0.75MG 0.75MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 75 mg/100 mL infusion vial 75 mg/100 mL infusion vial
ATC code B01AC B01AC
ATC description ANTITHROMBOTIC AGENTS ANTITHROMBOTIC AGENTS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2022-09-30 2022-09-26
Actual discontinuation date
Remaining supply date 2022-09-30 2022-09-26
Discontinuation status To be discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments